PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value-Reference-Cited by-同舟云学术

PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value

Published:2016-09-05 Issue:1 Volume:35 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Xu Jianwei,Xiong Guangbing,Cao Zhe,Huang Hua,Wang Tianxiao,You Lei,Zhou Li,Zheng Lianfang,Hu Ya,Zhang Taiping,Zhao Yupei

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

National Program on Key Basic Research Project(973 Program)

Research Special Fund for Public Welfare Industry of Health: the translational research of early diagnosis and comprehensive treatment in pancreatic cancer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-016-0406-z

Reference45 articles.

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.

2. Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Sarkar FH. Pancreatic cancer: understanding and overcoming chemoresistance. Nat Rev Gastroenterol Hepatol. 2011;8(1):27–33.

3. Gao Y, Zhu Y, Zhang Z, Zhang C, Huang X, Yuan Z. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization. J Exp Clin Cancer Res. 2016;35:66.

4. Liu Q, Li Y, Niu Z, Zong Y, Wang M, Yao L, Lu Z, Liao Q, Zhao Y. Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages. J Exp Clin Cancer Res. 2016;35:33.

5. Blanco-Aparicio C, Carnero A. Pim kinases in cancer: diagnostic, prognostic and treatment opportunities. Biochem Pharmacol. 2013;85(5):629–43.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights;Bioorganic Chemistry;2024-12

2. Targeting PIM kinases in cancer therapy: An update on pharmacological small-molecule inhibitors;European Journal of Medicinal Chemistry;2024-01

3. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma;Cells;2023-12-19

4. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor;PLOS ONE;2023-11-09

5. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer;Cell Chemical Biology;2023-11